NASDAQ: GAVA
Grayscale Avalanche Staking ETFCIK 0002035053 · SIC 6221 · Commodity Contracts Brokers & Dealers
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (SAR 10-Q) is open in full — no account needed.
Summary not yet generated.
Summary not yet generated.
Partner
Trade GAVA commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Latest financial statements
From 10-Q filed Aug 7, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Statements of Operations (Unaudited)
(Amounts in thousands)
| Description | Three months ended June 30, 2026 | Three months ended June 30, 2025 | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|---|---|
| Investment income: | ||||
| Staking Reward income | 47 | - | 57 | - |
| Investment income | - | - | - | - |
| Total Investment income | 47 | - | 57 | - |
| Expenses: | ||||
| Sponsor's Staking Fee, related party | 10 | - | 12 | - |
| Sponsor’s Fee, related party | 4 | 44 | 36 | 57 |
| Gross expenses | 14 | 44 | 48 | 57 |
| Sponsor's Fee Waiver, related party | (4) | - | (5) | - |
| Net expenses | 10 | 44 | 43 | 57 |
| Net investment gain (loss) | 37 | (44) | 14 | (57) |
| Net realized and unrealized loss from: | ||||
| Net realized loss on investment in AVAX sold to pay Sponsor’s Fee | (2) | (10) | (41) | (9) |
| Net realized loss on investment in AVAX sold to pay Sponsor's Staking Fee | (18) | - | (22) | - |
| Net realized gain on investment in AVAX sold for redemption of Shares | - | - | - | - |
| Net change in unrealized appreciation/depreciation on investment in AVAX | (1,433) | (3,548) | (3,395) | (4,852) |
| Net realized and unrealized loss | (1,453) | (3,558) | (3,458) | (4,861) |
| Net decrease in net assets resulting from operations | (1,416) | (3,602) | (3,444) | (4,918) |
Statements of Assets and Liabilities (Unaudited)
(Amounts in thousands, except Share and per Share amounts)
| Description | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Assets: | ||
| Investment in AVAX, at fair value (cost $15,093 and $14,518 as of June 30, 2026 and December 31, 2025, respectively) | 4,270 | 7,090 |
| Total assets | 4,270 | 7,090 |
| Liabilities: | ||
| Sponsor's Staking Fee payable, related party | - | - |
| Sponsor’s Fee payable, related party | - | - |
| Total liabilities | - | - |
| Net assets | 4,270 | 7,090 |
| Shares issued and outstanding, no par value (unlimited Shares authorized) | 267,980 | 237,980 |
| Principal Market NAV per Share | 15.93 | 29.79 |
Amounts as printed on the EDGAR/iXBRL face — (Amounts in thousands); (Amounts in thousands, except Share and per Share amounts). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗